Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Figure S3 from Exposure-Response Analyses of Tremelimumab Monotherapy or in Combination with Durvalumab in Patients with Unresectable Hepatocellular Carcinoma
  1. Home
  2. Publications
  3. Figure S3 from Exposure-Response Analyses of Tremelimumab Monotherapy or in Combination with Durvalumab in Patients with Unresectable Hepatocellular Carcinoma

Figure S3 from Exposure-Response Analyses of Tremelimumab Monotherapy or in Combination with Durvalumab in Patients with Unresectable Hepatocellular Carcinoma

Authors:
  • XSXuyang Song
    Xuyang Song
  • RKRobin Kate Kelley
    Robin Kate Kelley
  • AKAnis A. Khan
    Anis A. Khan
  • NSNathan Standifer
    Nathan Standifer
  • DZDiansong Zhou
    Diansong Zhou
  • KLKyoungSoo Lim
    KyoungSoo Lim
  • RKRajesh Krishna
    Rajesh Krishna
  • LLLu Liu
    Lu Liu
  • KWKun Wang
    Kun Wang
  • PMPatricia McCoon
    Patricia McCoon
  • ANAlejandra Negro
    Alejandra Negro
  • PHPhilip He
    Philip He

Open Access
Publisher website
Google Scholar
  • 25 November 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.30706760
Abstract
Supplementary Figure S3. CFB of proliferating CD8+Ki67+ T cells vs predicted tremelimumab exposure (PD analysis population) in patients with lower and higher baseline CD8+Ki67+ T-cell counts
Keywords
  • GASTROINTESTINAL CANCERS
  • LIVER CANCER
  • IMMUNOTHERAPY
  • PHARMACOLOGY
  • PHARMACOKINETICS AND PHARMACODYNAMICS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.